Drug-Drug Interaction (DDI) Study of Leramistat in Healthy Adult Subjects
ConditionPharmacokinetics
Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18-55
SponsorModern Biosciences Ltd
About this trial
A DDI study consisting of 4 parts conducted as an open label, fixed sequence study in healthy adult subjects.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- leramistat 40mg
- Itraconazole 200 mg
- Phenytoin 100 Mg Oral Capsule
- Simvastatin 40mg
- Upadacitinib 15 MG
Treatment groups
48 Participants
are divided into 4 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov